Allergan, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Employees
- 10.5K
- Market Cap
- -
Clinical Trials
18
Active:8
Completed:2
Trial Phases
4 Phases
Phase 1:4
Phase 2:2
Phase 3:5
+1 more phases
Drug Approvals
191
CANADA:63
FDA:62
SFDA:2
+1 more agencies
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (14 trials with phase data)• Click on a phase to view related trials
Phase 3
5 (35.7%)Phase 1
4 (28.6%)Not Applicable
3 (21.4%)Phase 2
2 (14.3%)No trials found
News
Allergan Botox Patent Infringement Trial Against Revance Set for July in Delaware
A Delaware federal judge has ruled that Allergan's patent infringement lawsuit against Revance Therapeutics will proceed to trial in July 2024, following the denial of summary judgment motions from both parties.